Table of Contents
104 relations: Akathisia, Aldehyde oxidase, Aldose reductase, Alpha-1 adrenergic receptor, Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-2A adrenergic receptor, Alpha-2B adrenergic receptor, Alpha-2C adrenergic receptor, Anticholinergic, Antipsychotic, Aripiprazole, Asenapine, Atypical antipsychotic, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Bioavailability, Bipolar disorder, Body mass index, Boxed warning, Brain, British National Formulary, Carbamazepine, Chlorpromazine, CYP3A4, Dementia, Diário Oficial da União, Dizziness, Dopamine, Dopamine receptor, Dopamine receptor D1, Dopamine receptor D2, Dopamine receptor D3, Dopamine receptor D4, Dopamine receptor D5, Drug rash with eosinophilia and systemic symptoms, Dystonia, Extrapyramidal symptoms, Fasciculation, Food and Drug Administration, Freeze drying, Groton, Connecticut, Haloperidol, Histamine H1 receptor, Histamine H2 receptor, Histamine H3 receptor, Histamine H4 receptor, Hyperglycemia, Iloperidone, Insulin resistance, ... Expand index (54 more) »
- Atypical antipsychotics
- Benzoisothiazoles
- Dopamine antagonists
- Mood stabilizers
- Oxindoles
- Substances discovered in the 1980s
Akathisia
Akathisia (IPA: /æ.kə.ˈθɪ.si.ə/) is a movement disorder characterized by a subjective feeling of inner restlessness accompanied by mental distress and an inability to sit still.
Aldehyde oxidase
Aldehyde oxidase (AO) is a metabolizing enzyme, located in the cytosolic compartment of tissues in many organisms.
See Ziprasidone and Aldehyde oxidase
Aldose reductase
In enzymology, aldose reductase (or aldehyde reductase) is a cytosolic NADPH-dependent oxidoreductase that catalyzes the reduction of a variety of aldehydes and carbonyls, including monosaccharides.
See Ziprasidone and Aldose reductase
Alpha-1 adrenergic receptor
alpha-1 (α1) adrenergic receptors are G protein-coupled receptors (GPCRs) associated with the Gq heterotrimeric G protein.
See Ziprasidone and Alpha-1 adrenergic receptor
Alpha-1A adrenergic receptor
The alpha-1A adrenergic receptor (α1A adrenoreceptor), also known as ADRA1A, formerly known also as the alpha-1C adrenergic receptor, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.
See Ziprasidone and Alpha-1A adrenergic receptor
Alpha-1B adrenergic receptor
The alpha-1B adrenergic receptor (α1B-adrenoreceptor), also known as ADRA1B, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.
See Ziprasidone and Alpha-1B adrenergic receptor
Alpha-2A adrenergic receptor
The alpha-2A adrenergic receptor (α2A adrenoceptor), also known as ADRA2A, is an α2 adrenergic receptor, and also denotes the human gene encoding it.
See Ziprasidone and Alpha-2A adrenergic receptor
Alpha-2B adrenergic receptor
The alpha-2B adrenergic receptor (α2B adrenoceptor), is a G-protein coupled receptor.
See Ziprasidone and Alpha-2B adrenergic receptor
Alpha-2C adrenergic receptor
The alpha-2C adrenergic receptor (α2C adrenoceptor), also known as ADRA2C, is an alpha-2 adrenergic receptor, and also denotes the human gene encoding it.
See Ziprasidone and Alpha-2C adrenergic receptor
Anticholinergic
Anticholinergics (anticholinergic agents) are substances that block the action of the acetylcholine (ACh) neurotransmitter at synapses in the central and peripheral nervous system.
See Ziprasidone and Anticholinergic
Antipsychotic
Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders. Ziprasidone and Antipsychotic are dopamine antagonists.
See Ziprasidone and Antipsychotic
Aripiprazole
Aripiprazole, sold under the brand names Abilify and Aristada, among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder; other uses include as an add-on treatment in major depressive disorder and obsessive compulsive disorder (OCD), tic disorders, and irritability associated with autism. Ziprasidone and Aripiprazole are atypical antipsychotics and mood stabilizers.
See Ziprasidone and Aripiprazole
Asenapine
Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder as well as the medium to long-term management of bipolar disorder. Ziprasidone and Asenapine are atypical antipsychotics and Chloroarenes.
Atypical antipsychotic
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric conditions. Ziprasidone and atypical antipsychotic are atypical antipsychotics.
See Ziprasidone and Atypical antipsychotic
Beta-1 adrenergic receptor
The beta-1 adrenergic receptor (β1 adrenoceptor), also known as ADRB1, can refer to either the protein-encoding gene (gene ADRB1) or one of the four adrenergic receptors.
See Ziprasidone and Beta-1 adrenergic receptor
Beta-2 adrenergic receptor
The beta-2 adrenergic receptor (β2 adrenoreceptor), also known as ADRB2, is a cell membrane-spanning beta-adrenergic receptor that binds epinephrine (adrenaline), a hormone and neurotransmitter whose signaling, via adenylate cyclase stimulation through trimeric Gs proteins, increases cAMP, and, via downstream L-type calcium channel interaction, mediates physiologic responses such as smooth muscle relaxation and bronchodilation.
See Ziprasidone and Beta-2 adrenergic receptor
Bioavailability
In pharmacology, bioavailability is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation.
See Ziprasidone and Bioavailability
Bipolar disorder
Bipolar disorder, previously known as manic depression, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks.
See Ziprasidone and Bipolar disorder
Body mass index
Body mass index (BMI) is a value derived from the mass (weight) and height of a person.
See Ziprasidone and Body mass index
Boxed warning
In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears near the beginning of the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text to emphasize it is of utmost importance.
See Ziprasidone and Boxed warning
Brain
The brain is an organ that serves as the center of the nervous system in all vertebrate and most invertebrate animals.
British National Formulary
The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS).
See Ziprasidone and British National Formulary
Carbamazepine
Carbamazepine, sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain. Ziprasidone and Carbamazepine are mood stabilizers.
See Ziprasidone and Carbamazepine
Chlorpromazine
Chlorpromazine (CPZ), marketed under the brand names Thorazine and Largactil among others, is an antipsychotic medication. Ziprasidone and Chlorpromazine are Chloroarenes.
See Ziprasidone and Chlorpromazine
CYP3A4
Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the intestine, which in humans is encoded by CYP3A4 gene.
Dementia
Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities.
Diário Oficial da União
The Diário Oficial da União (literally Official Diary of the Union), abbreviated DOU, is the official journal of the federal government of Brazil.
See Ziprasidone and Diário Oficial da União
Dizziness
Dizziness is an imprecise term that can refer to a sense of disorientation in space, vertigo, or lightheadedness.
Dopamine
Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is a neuromodulatory molecule that plays several important roles in cells.
Dopamine receptor
Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS).
See Ziprasidone and Dopamine receptor
Dopamine receptor D1
Dopamine receptor D1, also known as DRD1.
See Ziprasidone and Dopamine receptor D1
Dopamine receptor D2
Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2 gene.
See Ziprasidone and Dopamine receptor D2
Dopamine receptor D3
Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.
See Ziprasidone and Dopamine receptor D3
Dopamine receptor D4
The dopamine receptor D4 is a dopamine D2-like G protein-coupled receptor encoded by the gene on chromosome 11 at 11p15.5.
See Ziprasidone and Dopamine receptor D4
Dopamine receptor D5
Dopamine receptor D5, also known as D1BR, is a protein that in humans is encoded by the DRD5 gene.
See Ziprasidone and Dopamine receptor D5
Drug rash with eosinophilia and systemic symptoms
Drug rash with eosinophilia and systemic symptoms or drug reaction with eosinophilia and systemic symptoms (DRESS), also termed drug-induced hypersensitivity syndrome (DIHS), is a rare reaction to certain medications.
See Ziprasidone and Drug rash with eosinophilia and systemic symptoms
Dystonia
Dystonia is a neurological hyperkinetic movement disorder in which sustained or repetitive muscle contractions occur involuntarily, resulting in twisting and repetitive movements or abnormal fixed postures.
Extrapyramidal symptoms
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain's cerebral cortex.
See Ziprasidone and Extrapyramidal symptoms
Fasciculation
A fasciculation, or muscle twitch, is a spontaneous, involuntary muscle contraction and relaxation, involving fine muscle fibers.
See Ziprasidone and Fasciculation
Food and Drug Administration
The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.
See Ziprasidone and Food and Drug Administration
Freeze drying
Freeze drying, also known as lyophilization or cryodesiccation, is a low temperature dehydration process that involves freezing the product and lowering pressure, thereby removing the ice by sublimation.
See Ziprasidone and Freeze drying
Groton, Connecticut
Groton is a town in New London County, Connecticut located on the Thames River.
See Ziprasidone and Groton, Connecticut
Haloperidol
Haloperidol, sold under the brand name Haldol among others, is a typical antipsychotic medication. Ziprasidone and Haloperidol are Chloroarenes.
See Ziprasidone and Haloperidol
Histamine H1 receptor
The H1 receptor is a histamine receptor belonging to the family of rhodopsin-like G-protein-coupled receptors.
See Ziprasidone and Histamine H1 receptor
Histamine H2 receptor
H2 receptors are a type of histamine receptor found in many parts of the anatomy of humans and other animals.
See Ziprasidone and Histamine H2 receptor
Histamine H3 receptor
Histamine H3 receptors are expressed in the central nervous system and to a lesser extent the peripheral nervous system, where they act as autoreceptors in presynaptic histaminergic neurons and control histamine turnover by feedback inhibition of histamine synthesis and release.
See Ziprasidone and Histamine H3 receptor
Histamine H4 receptor
The histamine H4 receptor, like the other three histamine receptors, is a member of the G protein-coupled receptor superfamily that in humans is encoded by the HRH4 gene.
See Ziprasidone and Histamine H4 receptor
Hyperglycemia
Hyperglycemia or Hyperglycaemia is a condition in which an excessive amount of glucose circulates in the blood plasma.
See Ziprasidone and Hyperglycemia
Iloperidone
Iloperidone, commonly known as Fanapt and previously known as Zomaril, is an atypical antipsychotic for the treatment of schizophrenia. Ziprasidone and Iloperidone are atypical antipsychotics.
See Ziprasidone and Iloperidone
Insulin resistance
Insulin resistance (IR) is a pathological condition in which cells either fail to respond normally to the hormone insulin or downregulate insulin receptors in response to hyperinsulinemia.
See Ziprasidone and Insulin resistance
Intramuscular injection
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle.
See Ziprasidone and Intramuscular injection
Ketoconazole
Ketoconazole, sold under the brand name Nizoral among others, is an antiandrogen, antifungal, and antiglucocorticoid medication used to treat a number of fungal infections. Ziprasidone and Ketoconazole are Chloroarenes and Piperazines.
See Ziprasidone and Ketoconazole
Ligand (biochemistry)
In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.
See Ziprasidone and Ligand (biochemistry)
Long QT syndrome
Long QT syndrome (LQTS) is a condition affecting repolarization (relaxing) of the heart after a heartbeat, giving rise to an abnormally lengthy QT interval.
See Ziprasidone and Long QT syndrome
Lurasidone
Lurasidone, sold under the brand name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Ziprasidone and Lurasidone are atypical antipsychotics, Benzoisothiazoles, mood stabilizers and Piperazines.
See Ziprasidone and Lurasidone
Mania
Mania, also known as manic syndrome, is a mental and behavioral disorder defined as a state of abnormally elevated arousal, affect, and energy level, or "a state of heightened overall activation with enhanced affective expression together with lability of affect." During a manic episode, an individual will experience rapidly changing emotions and moods, highly influenced by surrounding stimuli.
Mesylate
In organosulfur chemistry, a mesylate is any salt or ester of methanesulfonic acid.
Mixed affective state
A mixed affective state, formerly known as a mixed-manic or mixed episode, has been defined as a state wherein features and symptoms unique to both depression and (hypo)mania, including episodes of anguish, despair, self doubt, rage, excessive impulsivity and suicidal ideation, sensory overload, racing thoughts, heightened irritability, decreased "need" for sleep and other symptoms of depressive and manic states occur either simultaneously or in very short succession.
See Ziprasidone and Mixed affective state
Muscarinic acetylcholine receptor M1
The muscarinic acetylcholine receptor M1, also known as the cholinergic receptor, muscarinic 1, is a muscarinic receptor that in humans is encoded by the CHRM1 gene.
See Ziprasidone and Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M2
The muscarinic acetylcholine receptor M2, also known as the cholinergic receptor, muscarinic 2, is a muscarinic acetylcholine receptor that in humans is encoded by the CHRM2 gene.
See Ziprasidone and Muscarinic acetylcholine receptor M2
Muscarinic acetylcholine receptor M3
The muscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or the muscarinic 3, is a muscarinic acetylcholine receptor encoded by the human gene CHRM3.
See Ziprasidone and Muscarinic acetylcholine receptor M3
Muscarinic acetylcholine receptor M4
The muscarinic acetylcholine receptor M4, also known as the cholinergic receptor, muscarinic 4 (CHRM4), is a protein that, in humans, is encoded by the CHRM4 gene.
See Ziprasidone and Muscarinic acetylcholine receptor M4
Muscarinic acetylcholine receptor M5
The human muscarinic acetylcholine receptor M5, encoded by the gene, is a member of the G protein-coupled receptor superfamily of integral membrane proteins.
See Ziprasidone and Muscarinic acetylcholine receptor M5
NMDA receptor
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and predominantly Ca2+ ion channel found in neurons.
See Ziprasidone and NMDA receptor
Olanzapine
Olanzapine, sold under the brand name Zyprexa among others, is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. Ziprasidone and Olanzapine are atypical antipsychotics, mood stabilizers and Piperazines.
See Ziprasidone and Olanzapine
Opioid receptor
Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands.
See Ziprasidone and Opioid receptor
Oral administration
| name.
See Ziprasidone and Oral administration
Orthostatic hypotension
Orthostatic hypotension, also known as postural hypotension, is a medical condition wherein a person's blood pressure drops when standing up or sitting down.
See Ziprasidone and Orthostatic hypotension
Parkinsonism
Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia (slowed movements), rigidity, and postural instability.
See Ziprasidone and Parkinsonism
Pfizer
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City.
Pharmacodynamics
Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs).
See Ziprasidone and Pharmacodynamics
Psychomotor agitation
Psychomotor agitation is a symptom in various disorders and health conditions.
See Ziprasidone and Psychomotor agitation
Psychosis
Psychosis is a condition of the mind or psyche that results in difficulties determining what is real and what is not real.
Quetiapine
Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. Ziprasidone and Quetiapine are atypical antipsychotics, mood stabilizers and Piperazines.
See Ziprasidone and Quetiapine
Reuptake
Reuptake is the reabsorption of a neurotransmitter by a neurotransmitter transporter located along the plasma membrane of an axon terminal (i.e., the pre-synaptic neuron at a synapse) or glial cell after it has performed its function of transmitting a neural impulse.
Reuptake inhibitor
Reuptake inhibitors (RIs) are a type of reuptake modulators.
See Ziprasidone and Reuptake inhibitor
Risperidone
Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Ziprasidone and Risperidone are atypical antipsychotics, mood stabilizers and serotonin receptor antagonists.
See Ziprasidone and Risperidone
Schizophrenia
Schizophrenia is a mental disorder characterized by reoccurring episodes of psychosis that are correlated with a general misperception of reality.
See Ziprasidone and Schizophrenia
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions.
See Ziprasidone and Selective serotonin reuptake inhibitor
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
Serotonin–norepinephrine reuptake inhibitor
Serotonin–norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant medications used to treat major depressive disorder (MDD), anxiety disorders, social phobia, chronic neuropathic pain, fibromyalgia syndrome (FMS), and menopausal symptoms.
See Ziprasidone and Serotonin–norepinephrine reuptake inhibitor
Sigma-1 receptor
The sigma-1 receptor (σ1R), one of two sigma receptor subtypes, is a chaperone protein at the endoplasmic reticulum (ER) that modulates calcium signaling through the IP3 receptor.
See Ziprasidone and Sigma-1 receptor
Sigma-2 receptor
The sigma-2 receptor (σ2R) is a sigma receptor subtype that has attracted attention due to its involvement in diseases such as neurological diseases, neurodegenerative, neuro-ophthalmic and cancer.
See Ziprasidone and Sigma-2 receptor
Somnolence
Somnolence (alternatively sleepiness or drowsiness) is a state of strong desire for sleep, or sleeping for unusually long periods (compare hypersomnia).
See Ziprasidone and Somnolence
Structural analog
A structural analog, also known as a chemical analog or simply an analog, is a compound having a structure similar to that of another compound, but differing from it in respect to a certain component.
See Ziprasidone and Structural analog
Tardive dyskinesia
Tardive dyskinesia (TD) is a disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips.
See Ziprasidone and Tardive dyskinesia
Type 2 diabetes
Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.
See Ziprasidone and Type 2 diabetes
United States Department of Justice
The United States Department of Justice (DOJ), also known as the Justice Department, is a federal executive department of the United States government tasked with the enforcement of federal law and administration of justice in the United States.
See Ziprasidone and United States Department of Justice
Upjohn
The Upjohn Company was an American pharmaceutical manufacturing firm founded in 1886 in Hastings, Michigan, by Dr.
Viatris
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania.
Weight gain
Weight gain is an increase in body weight.
See Ziprasidone and Weight gain
Xerostomia
Xerostomia, also known as dry mouth, is a subjective complaint of dryness in the mouth, which may be associated with a change in the composition of saliva, or reduced salivary flow, or have no identifiable cause.
See Ziprasidone and Xerostomia
5-HT receptor
5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.
See Ziprasidone and 5-HT receptor
5-HT1A receptor
The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptors, or 5-HT receptors, that binds serotonin, also known as 5-HT, a neurotransmitter.
See Ziprasidone and 5-HT1A receptor
5-HT1B receptor
5-hydroxytryptamine receptor 1B also known as the 5-HT1B receptor is a protein that in humans is encoded by the HTR1B gene.
See Ziprasidone and 5-HT1B receptor
5-HT1D receptor
5-hydroxytryptamine (serotonin) receptor 1D, also known as HTR1D, is a 5-HT receptor, but also denotes the human gene encoding it.
See Ziprasidone and 5-HT1D receptor
5-HT1E receptor
5-hydroxytryptamine (serotonin) 1E receptor (5-HT1E) is a highly expressed human G-protein coupled receptor that belongs to the 5-HT1 receptor family (Gi-coupled serotonin receptor).
See Ziprasidone and 5-HT1E receptor
5-HT2A receptor
The 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).
See Ziprasidone and 5-HT2A receptor
5-HT2B receptor
5-Hydroxytryptamine receptor 2B (5-HT2B) also known as serotonin receptor 2B is a protein that in humans is encoded by the HTR2B gene.
See Ziprasidone and 5-HT2B receptor
5-HT2C receptor
The 5-HT2C receptor is a subtype of the 5-HT2 receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
See Ziprasidone and 5-HT2C receptor
5-HT3 receptor
The 5-HT3 receptor belongs to the Cys-loop superfamily of ligand-gated ion channels (LGICs) and therefore differs structurally and functionally from all other 5-HT receptors (5-hydroxytryptamine, or serotonin receptors) which are G protein-coupled receptors.
See Ziprasidone and 5-HT3 receptor
5-HT5A receptor
5-Hydroxytryptamine (serotonin) receptor 5A, also known as HTR5A, is a protein that in humans is encoded by the HTR5A gene.
See Ziprasidone and 5-HT5A receptor
5-HT6 receptor
The 5HT6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5HT).
See Ziprasidone and 5-HT6 receptor
5-HT7 receptor
The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
See Ziprasidone and 5-HT7 receptor
See also
Atypical antipsychotics
- Amisulpride
- Amoxapine
- Aripiprazole
- Aripiprazole/sertraline
- Asenapine
- Atypical antipsychotic
- Bifeprunox
- Blonanserin
- Brexpiprazole
- Brilaroxazine
- Bromerguride
- Cariprazine
- Carpipramine
- Clocapramine
- Clotiapine
- Clozapine
- Cycloserine/lurasidone
- DHA-clozapine
- Gevotroline
- Iloperidone
- Lumateperone
- Lurasidone
- Melperone
- Mosapramine
- Nemonapride
- Olanzapine
- Olanzapine/fluoxetine
- Olanzapine/samidorphan
- Paliperidone
- Perospirone
- Pimavanserin
- Piquindone
- Quetiapine
- Remoxipride
- Risperidone
- Sertindole
- Sulpiride
- Sultopride
- Tenilapine
- Tiapride
- Zicronapine
- Ziprasidone
- Zotepine
Benzoisothiazoles
- Lurasidone
- Perospirone
- Ziprasidone
Dopamine antagonists
- AS-8112
- Alizapride
- Amitriptyline
- Amoxapine
- Antipsychotic
- Atypical antipsychotics
- Azapride
- Bromerguride
- Bromopride
- Butaclamol
- Cariprazine
- Clebopride
- Clomipramine
- Clozapine
- Cyamemazine
- Cyproheptadine
- DHA-clozapine
- Dixyrazine
- Domperidone
- Dopamine antagonist
- Ecopipam
- Fluphenazine
- Levofenfluramine
- List of dopaminergic drugs
- Melperone
- Metiapine
- Metitepine
- N-Methylspiperone
- Nafadotride
- Olanzapine/fluoxetine
- Olanzapine/samidorphan
- PNU-99,194
- Perlapine
- Perphenazine
- Perphenazine enanthate
- Spiroxatrine
- Triflupromazine
- Trimipramine
- Typical antipsychotics
- UH-232
- Ziprasidone
Mood stabilizers
- Aripiprazole
- Carbamazepine
- Cariprazine
- Clozapine
- Histone deacetylase inhibitor
- Lamotrigine
- Licarbazepine
- List of adverse effects of valproate semisodium
- List of antidepressants
- List of investigational antidepressants
- Lithium (medication)
- Lithium bromide
- Lithium carbonate
- Lithium chloride
- Lithium citrate
- Lithium orotate
- Lithium sulfate
- Lurasidone
- Mood stabilizer
- Olanzapine
- Olanzapine/fluoxetine
- Oxcarbazepine
- Paliperidone
- Quetiapine
- Risperidone
- Tamoxifen
- Valnoctamide
- Valproate
- Valproate pivoxil
- Valpromide
- Ziprasidone
Oxindoles
- 14-Hydroxygelsenicine
- 2-Indolinethione
- Amedalin
- Coerulescine
- Doliracetam
- Gelsemine
- Horsfiline
- Linopirdine
- Metisazone
- Oxindole
- Rhynchophylline
- SM-130686
- Semaxanib
- Ziprasidone
Substances discovered in the 1980s
- 2C-T-2
- Digallane
- Dodecahedrane
- Gold heptafluoride
- Malonic anhydride
- Oximide
- Pagodane
- Pentacarbon dioxide
- Phosphole
- Ziprasidone
References
Also known as ATC code N05AE04, ATCvet code QN05AE04, C21H21ClN4OS, Geodom, Geodon, Geodone, Zaprasidone, Zeldox, Ziprasadone, Ziprasidone HCl, Ziprasidone Hydrochloride, Ziprasidone mesylate.